Table 5.

Receiver operating characteristic analysis of FIT and PGE-MUM for predicting relapse in the short-term disease duration group

Disease duration	AUC [95% CI]		P-value
	FIT	PGE-MUM
<30 yr (n = 71)	0.725 [0.602–0.849]	0.700 [0.558–0.842]	0.810
<25 yr (n = 66)	0.737 [0.609–0.864]	0.756 [0.618–0.894]	0.859
<20 yr (n = 60)	0.743 [0.612–0.875]	0.737 [0.589–0.885]	0.953
<15 yr (n = 55)	0.759 [0.625–0.892]	0.726 [0.568–0.884]	0.780
<11 yr (n = 51)	0.733 [0.591–0.876]	0.704 [0.529–0.878]	0.819
<10 yr (n = 46)	0.741 [0.593–0.889]	0.663 [0.477–0.849]	0.560
<9 yr (n = 42)	0.784 [0.641–0.928]	0.651 [0.462–0.839]	0.307
<8 yr (n = 38)	0.755 [0.595–0.915]	0.609 [0.399–0.819]	0.330
<7 yr (n = 36)	0.731 [0.561–0.901]	0.589 [0.368–0.810]	0.378
<6 yr (n = 34)	0.719 [0.544–0.895]	0.581 [0.359–0.803]	0.393
<5 yr (n = 28)	0.702 [0.503–0.900]	0.526 [0.275–0.778]	0.337

AUC, area under the curve; CI, confidence interval; FIT, fecal immunochemical occult blood test; PGE-MUM, prostaglandin E-major urinary metabolite.